loading
Precedente Chiudi:
$2.96
Aprire:
$2.94
Volume 24 ore:
42,827
Relative Volume:
0.02
Capitalizzazione di mercato:
$4.30M
Reddito:
-
Utile/perdita netta:
$-6.91M
Rapporto P/E:
-0.4155
EPS:
-6.69
Flusso di cassa netto:
$-6.14M
1 W Prestazione:
-10.32%
1M Prestazione:
-40.60%
6M Prestazione:
-40.52%
1 anno Prestazione:
-35.67%
Intervallo 1D:
Value
$2.75
$2.94
Intervallo di 1 settimana:
Value
$2.75
$3.12
Portata 52W:
Value
$2.73
$23.80

Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile

Name
Nome
Galmed Pharmaceuticals Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
8
Name
Cinguettio
@GalmedPharma
Name
Prossima data di guadagno
2024-11-20
Name
Ultimi documenti SEC
Name
GLMD's Discussions on Twitter

Confronta GLMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
GLMD 2.76 4.30M 0 -6.91M -6.14M -6.69
VRTX 450.63 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.04 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.57 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.97 24.89B 3.30B -501.07M 1.03B 11.54

Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-05-22 Downgrade B. Riley FBR Buy → Neutral
2020-02-04 Iniziato Craig Hallum Buy
2020-01-30 Ripresa Cantor Fitzgerald Overweight
2019-12-02 Iniziato Canaccord Genuity Buy
2018-12-12 Iniziato B. Riley FBR Buy
2018-08-02 Reiterato Maxim Group Buy
2018-07-13 Iniziato Stifel Buy
2018-07-12 Iniziato Cantor Fitzgerald Overweight
2018-06-12 Reiterato H.C. Wainwright Buy
2018-03-15 Aggiornamento Maxim Group Hold → Buy
2018-02-14 Downgrade Maxim Group Buy → Hold
2018-02-12 Reiterato H.C. Wainwright Buy
2017-11-15 Iniziato ROTH Capital Buy
2017-08-08 Reiterato H.C. Wainwright Buy
2017-07-31 Reiterato Maxim Group Buy
2016-08-01 Reiterato Maxim Group Buy
2016-07-06 Ripresa ROTH Capital Buy
2016-03-28 Ripresa H.C. Wainwright Buy
2015-06-23 Iniziato H.C. Wainwright Buy
2015-05-06 Iniziato Sun Trust Rbsn Humphrey Buy
Mostra tutto

Galmed Pharmaceuticals Ltd Borsa (GLMD) Ultime notizie

pulisher
Nov 16, 2024

Galmed Pharmaceuticals: Q3 Earnings Snapshot - New Haven Register

Nov 16, 2024
pulisher
Nov 14, 2024

Galmed Pharmaceuticals Embraces Market with New Sales Agreement - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 12, 2024

Galmed Phar stock hits 52-week low at $2.73 amid challenges - Investing.com Australia

Nov 12, 2024
pulisher
Oct 21, 2024

Galmed Pharmaceuticals Amends Equity Purchase Agreement - TipRanks

Oct 21, 2024
pulisher
Oct 11, 2024

Acyl CoA Desaturase Market Current Status and Future Prospects - IndiaPolitics.com

Oct 11, 2024
pulisher
Oct 04, 2024

galmed pharmaceuticals ltd. Earnings dates - RTTNews

Oct 04, 2024
pulisher
Oct 01, 2024

Galmed Pharmaceuticals (NASDAQ:GLMD) Stock Passes Above 50-Day Moving Average of $4.52 - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN

Oct 01, 2024
pulisher
Sep 26, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - MSN

Sep 26, 2024
pulisher
Sep 26, 2024

(GLMD) Long Term Investment Analysis - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Galmed reports positive results for Aramchol in NASH study By Investing.com - Investing.com Australia

Sep 26, 2024
pulisher
Sep 25, 2024

Galmed reports positive results for Aramchol in NASH study - Investing.com India

Sep 25, 2024
pulisher
Sep 25, 2024

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology - PR Newswire

Sep 25, 2024
pulisher
Sep 25, 2024

Post-Trade Analysis: Galmed Pharmaceuticals Ltd (GLMD) Slides -13.90, Closing at 8.05 - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

Take off with Galmed Pharmaceuticals Ltd (GLMD): Get ready for trading - SETE News

Sep 24, 2024
pulisher
Sep 23, 2024

Understanding GLMD stock ratios for better investment decisions - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

GLMD’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Optimistic Market Report Drives Galmed Pharmaceuticals (GLMD) Stock Upward - Stocks Telegraph

Sep 23, 2024
pulisher
Sep 20, 2024

How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

Galmed Pharmaceuticals Calls for Capital Increase Vote - TipRanks

Sep 20, 2024
pulisher
Sep 19, 2024

Galmed expands drug development to cancer and heart diseases - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

Galmed surges on plans to expand into cancer and heart disease drug development - XM

Sep 19, 2024
pulisher
Sep 19, 2024

Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why - Benzinga

Sep 19, 2024
pulisher
Sep 19, 2024

Market Insights: Galmed Pharmaceuticals Ltd (GLMD)’s Notable Drop of -54.30, Closing at 6.90 - The Dwinnex

Sep 19, 2024
pulisher
Sep 19, 2024

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases - PR Newswire

Sep 19, 2024
pulisher
Sep 19, 2024

Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases | GLMD Stock News - StockTitan

Sep 19, 2024
pulisher
Sep 18, 2024

B. Riley FBR Downgrades Galmed Pharmaceuticals Ltd (GLMD) to a Neutral from a Buy - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Galmed Pharmaceuticals Down 53%, But Still Well Above Monday Closing Price - MarketWatch

Sep 18, 2024
pulisher
Sep 18, 2024

US Stocks Mixed; General Mills Posts Upbeat Earnings - Benzinga

Sep 18, 2024
pulisher
Sep 18, 2024

A new trading data show Galmed Pharmaceuticals Ltd (GLMD) is showing positive returns. - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Galmed Pharmaceuticals Soars Nearly 500% Amid Nasdaq Compliance and Short Squeeze - TipRanks

Sep 18, 2024
pulisher
Sep 17, 2024

Those who invested in Neuren Pharmaceuticals (ASX:NEU) three years ago are up 576% - Yahoo Finance

Sep 17, 2024
pulisher
Sep 17, 2024

Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Gold Edges Lower; US Homebuilder Sentiment Rises For September - Benzinga

Sep 17, 2024
pulisher
Sep 17, 2024

Galmed Pharmaceuticals Surges After Regaining Nasdaq Compliance - MarketWatch

Sep 17, 2024
pulisher
Sep 17, 2024

Galmed Pharmaceuticals Ltd’s Banking’s 100-Day Moving Average at 4.01: Will the Stock Break Through? - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Stock Market news: Galmed Pharmaceuticals soars 283%, Intel up 3.49%, while Tupperware plunges 57% - Business Upturn

Sep 17, 2024
pulisher
Sep 17, 2024

Express Scripts sues FTC and demands drug pricing report retraction - Yahoo! Voices

Sep 17, 2024
pulisher
Sep 17, 2024

With its newest mac and cheese, Stouffer's expands beyond the freezer aisle to supermarket shelves - Yahoo! Voices

Sep 17, 2024
pulisher
Sep 17, 2024

Merit Medical touts positive six-month data from WAVE trial - Yahoo! Voices

Sep 17, 2024
pulisher
Sep 17, 2024

Lunds & Byerlys digitizes refrigeration compliance management - Yahoo! Voices

Sep 17, 2024
pulisher
Sep 17, 2024

Crude Oil Gains Over 1%; US Business Inventories Increase In July - Benzinga

Sep 17, 2024
pulisher
Sep 17, 2024

Philip Morris to sell Vectura for $198 million after health shift criticism - Yahoo Finance

Sep 17, 2024
pulisher
Sep 17, 2024

Why Shares of Gannett Are Soaring Today - Yahoo Finance

Sep 17, 2024
pulisher
Sep 17, 2024

Galmed Pharma stock hits 52-week high at $10.51 - Investing.com

Sep 17, 2024
pulisher
Sep 17, 2024

FanDuel Parent Buys Italian Gaming Operator Snai for $2.56 Billion - Yahoo! Voices

Sep 17, 2024
pulisher
Sep 17, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution - Yahoo Finance

Sep 17, 2024
pulisher
Sep 17, 2024

Intel's Amazon chip deal lifts investor confidence in money-losing foundry unit - Yahoo! Voices

Sep 17, 2024
pulisher
Sep 17, 2024

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Yahoo Finance

Sep 17, 2024
pulisher
Sep 17, 2024

Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results - Yahoo Finance

Sep 17, 2024

Galmed Pharmaceuticals Ltd Azioni (GLMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):